Genome Therapeutics

Genome therapeutics email format

Verified email-pattern data for Genome Therapeutics is currently limited. You can still use the company insights and contact sections below.
Founded in 2022, Genome Therapeutics (GTx) was formed to advance pioneering academic research from the laboratories of Professor Sir Shankar Balasubramanian at the University of Cambridge and Professor Samuel Aparicio at the University of British Colombia. GTx is developing novel therapies that target secondary DNA structures called G-quadruplexes (G4) that are overrepresented in cancer cells. This novel approach to cancer therapeutics is underpinned by 25 years’ of academic research, paving the way for GTx to develop first-in-class therapies that precisely target the underlying genetic drivers of cancer and avoid the indiscriminate toxicity profile of classical chemotherapy agents.

Company Details

Employees
9
Founded
-
Address
Lensfield Road, Yusuf Hamied,dept. Of Chemistry,united Kingdom
Industry
Biotechnology Research
Keywords
London.
HQ
Cambridge, England
Looking for a particular Genome Therapeutics employee's phone or email?

Genome Therapeutics Questions

Top Genome Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant